
India · Medical devices startup
Molbio Diagnostics is an Indian healthcare technology company focused on molecular diagnostics and point-of-care testing solutions.
Funding reportedLast round: Undisclosed round
Follow Molbio Diagnostics and see its new rounds in your feed.Start following
Molbio Diagnostics is an Indian healthcare technology company focused on molecular diagnostics and point-of-care testing solutions.
Founded in 2000 and headquartered in Verna, Goa, the company aims to decentralize healthcare by providing rapid and cost-effective diagnostic solutions, particularly in remote and resource-limited settings. With a presence in over 85 countries and a workforce of approximately 616 employees, Molbio has established itself as a global leader in the diagnostic equipment industry. The company offers a range of diagnostic services, including point-of-care molecular testing for infectious diseases and non-communicable diseases, drug resistance monitoring, and AI-driven diagnostics. Its flagship product, the Truenat® platform, is a portable real-time PCR system endorsed by the WHO, capable of testing for over 40 diseases. Molbio also emphasizes sustainability and innovation, with plans for future growth and expansion into high-income markets while maintaining a commitment to global health equity.
Funding, as reported
From Molbio Diagnostics's own website: 12 on the team.
What they build
Known for
infectious disease detectionpcr platformhealth caremedical innovationdigital healthhigh-burden diseasechip-based testingmolecular diagnosticsmulti-pathogen pcr assaysmicro pcr systemhealthcare deliverydiagnostic testing for virusespcr technology for resource-limited settingsrifampicin resistance testingdisease diagnosisportable diagnostic devices
Built with from their website
Google MapsContact Form 7Salesforce Service CloudExcel ImpactGoogle SheetsTableauLiteSpeedWordPress.orgDataTablesFlow
Font AwesomeElementorCloudFlareViewport MetaLinkedIn AdsHello ElementorSAP Crystal SolutionsMicrosoft Excel
Add your raise, your deck and your story, and put Molbio Diagnostics in front of investors. Or tell us what we have wrong.